Clinical trials
Recruiting Phase 1 Schizophrenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anxo Pharmaceutical Co., Ltd. | 1 |
| BioXcel Therapeutics Inc | 1 |
| Bristol-Myers Squibb | 1 |
| Davidzon, Guido, M.D. | 1 |
| Janssen Research & Development, LLC | 1 |
| Leal Therapeutics, Inc | 1 |
| Luye Pharma Group Ltd. | 1 |
| Neurosterix | 1 |
| Sichuan Kelun Pharmaceutical Co.,Ltd. | 1 |
| Vigonvita Life Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 11 |
| Bipolar Disorder | 1 |
| Psychotic Disorders | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.